Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
An update from Inogen ( (INGN) ) is now available.
On January 30, 2025, Thomas A. West resigned from his position as a director on Inogen’s Board, with no disagreements reported with the company’s operations. The following day, Mira Kirti Sahney was appointed to the Board, bringing extensive experience from her roles in various medical device companies, which is expected to bolster Inogen’s leadership as it seeks to strengthen its position in the respiratory care industry. Sahney will assume roles on the Compliance Committee and Nominating and Governance Committee, with her compensation aligned with the company’s director policy.
More about Inogen
Inogen, Inc. is a global medical technology company specializing in innovative respiratory products designed for homecare settings. The company focuses on delivering respiratory therapy devices to patients with chronic respiratory conditions, collaborating with patients, prescribers, and distributors to ensure wide availability of its products.
YTD Price Performance: 27.20%
Average Trading Volume: 223,633
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $278.4M
See more data about INGN stock on TipRanks’ Stock Analysis page.
